Pith. sign in

REVIEW 4 major objections 5 minor 36 references

High-resolution deuterium metabolic imaging of the human brain at 9.4 T using bSSFP spectral-spatial acquisitions

T0 review · 4 major / 5 minor · reviewed 2026-08-09 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Phase-cycled balanced SSFP acquisitions are feasible for high-resolution deuterium metabolic imaging of the human brain at 9.4 T, with CSI-bSSFP improving glucose and Glx SNR by 18% and 27% over standard gradient-spoiled CSI with IDEAL…

desk verdict A solid feasibility study showing bSSFP DMI works in the human brain at 9.4 T, but the headline 18%/27% SNR gain is likely optimistic because the IDEAL-modes combination step can overfit noise. read the letter →

arxiv 2501.18567 v1 pith:YZGF3L36 submitted 2025-01-30 physics.med-ph

Praveen Iyyappan Valsala , Rolf Pohmann , Rahel Heule , Georgiy A. Solomakha , Nikolai I. Avdievich , Jörn Engelmann , Laura Kuebler , André F. Martins
show 1 more author
Klaus Scheffler
This is my paper · ORCID
classification physics.med-ph
keywords deuteriummetabolicimagingbalancedSSFPphasecyclingultra-high-fieldMRISNRIDEALglucosemetabolismhumanbrain
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Deuterium metabolic imaging (DMI) tracks glucose uptake and downstream metabolism after oral intake of deuterated glucose, but its low signal has kept spatial resolution coarse. This paper tries to break that limit with balanced steady-state free precession (bSSFP), a steady-state sequence that refocuses magnetization every repetition and can give more signal per unit time for metabolites with favorable T2/T1. The authors show that phase-cycled CSI-bSSFP and ME-bSSFP both yield whole-brain dynamic quantitative DMI maps at 9.4 T in 10 minutes, with nominal voxels of 0.58 mL for the CSI variants. The central quantitative result is an average SNR gain of 18% for glucose and 27% for Glx (glutamate+glutamine) for CSI-bSSFP relative to the vendor's gradient-spoiled CSI-FISP with IDEAL processing. ME-bSSFP did not improve SNR but delivered a true 2.18 mL voxel volume and finer spatial detail, including resolved skull uptake.

What carries the argument

The working object is phase-cycled balanced steady-state free precession (bSSFP), a steady-state sequence in which transverse magnetization is fully refocused each TR and the RF phase is stepped across a cycle; the phase cycling removes off-resonance banding and adds a spectral-encoding dimension. The IDEAL-modes fit separates the bSSFP configuration modes by a discrete Fourier transform over phase cycles and combines mode amplitudes with weights from a principal-eigenvector analysis, while the linear fit matches the data to the full analytical bSSFP signal equation including T1, T2, off-resonance, flip angle, and RF phase increment. The comparison is normalized to resolution by SNR-units reconstruction and point-spread-function voxel-volume scaling factors of 0.96 and 1.31 for CSI-bSSFP and ME-bSSFP, respectively.

What would settle it

Reanalyze the same raw data with an independent point-spread-function estimation and with matched nominal resolutions, or run the three protocols on a phantom with known deuterium concentrations over a range of B0 offsets; if CSI-bSSFP no longer shows a resolution-normalized SNR gain over CSI-FISP in a larger subject cohort, the central claim is not supported.

Watch

Extended reading notes

Core claim

On its own terms, the paper establishes that bSSFP acquisitions with phase cycling are a viable sensitivity route for deuterium metabolic imaging of the human brain at 9.4 T. After oral [6,6'-2H2]-glucose intake, both CSI-bSSFP (four phase cycles, Hamming-weighted) and ME-bSSFP (eighteen phase cycles, elliptical scanning) produced high-resolution whole-brain maps of water, glucose, Glx, and lactate/lipids with no visible banding artifacts. Compared with the standard gradient-spoiled CSI-FISP plus IDEAL, CSI-bSSFP raised average SNR by 18% for glucose and 27% for Glx, while ME-bSSFP showed lower SNR but a true resolution close to its nominal 2 mL. Two proposed fitting methods, IDEAL-modes and linear fit, handle the amplitude and phase modulations introduced by phase cycling, and the authors demonstrate that phase cycling itself contributes extra spectral encoding that can separate all four deuterium resonances even with fewer echoes.

Load-bearing premise

The fairness of the headline SNR comparison depends on the point-spread-function voxel-volume scaling (factors 0.96 and 1.31) and the SNR-units normalization; if those corrections are biased, the reported 18 and 27 percent gains for CSI-bSSFP could change, and the in vivo comparison used only three subjects with no confidence intervals.

Editorial extensions

If this is right

  • DMI at 9.4 T can be done at 0.58 mL nominal voxel size in 10 minutes, about five times finer than earlier 3 mL studies at the same site.
  • CSI-bSSFP with phase cycling should give 18% better glucose and 27% better Glx SNR than standard CSI-FISP, gains that could be spent on smaller voxels, lower tracer dose, or shorter exams.
  • ME-bSSFP, despite no SNR benefit, provides actual resolution near its nominal 2 mL and can reveal spatially detailed features such as skull glucose uptake.
  • Phase cycling supplies enough extra spectral encoding to separate all four deuterium resonances with fewer than four echoes, which could shorten TR in future protocol designs.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • My inference: if the 18%/27% SNR gains reproduce in a larger cohort with confidence intervals, CSI-bSSFP could become the default DMI readout at ultra-high field, with the gain spent on reducing scan duration.
  • My inference: because the IDEAL-modes method only assumes chemical shift and B0, it should transfer to other field strengths and tissues with unknown relaxation times; a direct test would be comparing it with the linear fit in a tumor model.
  • My inference: the SNR comparison hinges on the PSF scaling factors 0.96 and 1.31; recomputing the comparison with an independent PSF measurement or matched nominal resolution would isolate how much of the reported gain is sequence physics versus normalization.
  • My inference: the additional spectral encoding from phase cycling implies TR can be shortened below the value needed for conventional spectral separation; this can be tested by reducing echo spacing while keeping four phase cycles and checking conditioning.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 5 minor

Summary. The manuscript reports a feasibility study of balanced SSFP (bSSFP) acquisitions for deuterium metabolic imaging (DMI) of the human brain at 9.4 T. Two bSSFP variants are implemented and compared with the vendor gradient-spoiled CSI-FISP sequence with IDEAL processing: an acquisition-weighted CSI-bSSFP and a multi-echo bSSFP (ME-bSSFP), both with RF phase cycling. The authors measure in vivo T1, T2, and T2* of deuterated water, glucose, Glx, and lactate; use these values in steady-state simulations to optimize the protocols; validate spectral separation on a phantom; and acquire interleaved 10-minute DMI scans in three healthy volunteers. They report that phase cycling improves off-resonance robustness and adds spectral encoding, that CSI-bSSFP yields an average SNR increase of 18% for glucose and 27% for Glx over CSI-FISP, and that ME-bSSFP provides higher nominal spatial resolution but lower or comparable SNR. The conclusion is that bSSFP DMI is feasible at 9.4 T and has potential to improve sensitivity, although the measured gains are smaller than the simulated predictions.

Significance. If the 18%/27% SNR advantage is robust, this is a useful incremental advance for human DMI at 9.4 T: higher-resolution metabolic maps within the same 10-minute acquisition time would improve the practicality of DMI. The paper's strengths include open data and code (GitHub/Zenodo), phantom validation for all four relevant deuterium resonances, interleaved in vivo acquisitions to reduce metabolic-dynamics confounds, and candid reporting of results that do not match the simulations: the measured gains are explicitly lower than the 45%/69% predictions, the ME-bSSFP SNR shortfall is discussed, and subject-2 B0-related artifacts are shown. The main caveat is that the quantitative CSI-bSSFP advantage depends on a data-driven eigenvector combination step that is applied to the same data used for SNR evaluation and is not symmetrically applied to the CSI-FISP reference; the robustness of the headline numbers therefore needs to be demonstrated before the exact gain is accepted.

major comments (4)
  1. [Spectral fitting; IDEAL-modes fit] The IDEAL-modes method obtains the complex weights for combining SSFP configuration modes by taking the principal eigenvector of the fitted metabolite amplitudes from the same phase-cycled bSSFP data that are then used to compute the SNR maps. This is a data-driven matched filter: it selects the linear combination that maximizes the apparent signal in the very noise realization being analyzed, and the bias is expected to be largest for low-SNR metabolites such as glucose and Glx, which are exactly the metabolites for which the headline 18%/27% gains are reported. The CSI-FISP reference is processed with standard IDEAL and receives no equivalent data-driven selection, so the comparison is asymmetric. The resemblance of the eigenvectors to simulated SSFP mode decay (Supporting Information Figure S6) is suggestive but is not a quantitative guard against inflation. Please reanalyze the bSSFP data with weights estimated from one half of the interleaved averages and applied to the other half, or with weights fixed to the simulated SSFP mode amplitudes, and report the resulting glucose/Glx gains.
  2. [Results; In vivo DMI studies (Figure 5)] The central quantitative claim — an average SNR increase of 18% for glucose and 27% for Glx for CSI-bSSFP over CSI-FISP — is based on three subjects and is reported without confidence intervals, a subject-level breakdown, or a precise definition of the whole-brain ROI used for the comparison. The text states a range of 9–29% for glucose, which is wide relative to the claimed 18% mean; this matters because the abstract presents 18%/27% as the main positive result. Please provide per-subject values, a pooled estimate with uncertainty (e.g., bootstrap or a t-interval), and a clear description of how the ROI was defined and whether the interleaved SNR maps were averaged before or after computing the percentage change.
  3. [SNR calculation] The SNR maps are scaled to SNR units using the Euclidean norm of the complex linear combination coefficients of the individual metabolites during spectral separation. This norm is method-dependent: it is derived from the standard IDEAL separation for CSI-FISP and from the IDEAL-modes or linear-fit procedures for the bSSFP data. Since the intended comparison is acquisition-related SNR, the manuscript should state explicitly whether the same scaling convention is applied to all three methods and quantify how sensitive the 18%/27% numbers are to the choice of scaling, for example by recomputing with a fixed theoretical weighting rather than the eigenvector-derived norm. Without this, part of the reported gain could be a reconstruction-scaling effect rather than a true SNR improvement.
  4. [Simulation; Figure 2] The simulations predict a 45% SNR increase for glucose and 69% for Glx for bSSFP relative to FISP, whereas the measured values are 18% and 27%. The discussion offers plausible explanations (FISP already near-optimal, phase-cycling stopband loss, SAR-limited flip angles), but the gap is large and no quantitative decomposition is provided. Because the headline result is a measured gain, it would strengthen the paper to show a revised simulation that includes the actual achieved flip angles (stated as 85–90% of nominal), the phase-cycle averaging penalty, and the measured B0 distribution, and to compare that revised prediction with the observed gains.
minor comments (5)
  1. [Table 1] The FOV entry for CSI-bSSFP is listed as '20x20x200' and appears to be a typo for '20x20x20'; please correct it.
  2. [Methods; DMI protocols] The phrase 'to improve maximize ADC duty cycle' is ungrammatical; it should read 'to improve ADC duty cycle' or 'to maximize ADC duty cycle'.
  3. [References and text] The citation to Nguyen and Bieri is misspelled as 'Nyugen' in the text, and Reference 16 should read 'Oppelt' rather than 'Opplet'.
  4. [Discussion] The sentence 'The bi-exponential T1 relaxation of in vivo water was not apparent in the inversion recovery data' is confusing because the following sentence and Table 2 concern bi-exponential T2 relaxation; please rephrase to avoid ambiguity.
  5. [Figure 8] The claim that ME-bSSFP Glx maps 'consistently predict higher concentrations' than the CSI methods is presented without a cross-method calibration phantom; if this is intended as a resolution/partial-volume effect, a brief quantitative justification would help.

Circularity Check

0 steps flagged · score 1.0 of 10

No significant circularity: the central SNR comparison is an empirical measurement against a vendor CSI reference, and the simulation predictions are checked against, not derived from, the measured SNR gains.

full rationale

The paper's main quantitative claim is that CSI-bSSFP provides an average SNR increase of 18% for glucose and 27% for Glx compared with the vendor's gradient-spoiled CSI. This is presented as an in vivo comparison of interleaved acquisitions, not as a quantity defined into existence. The simulation section predicts bSSFP gains of 7%, 45% and 69% for water, glucose and Glx from an analytical signal model using separately measured non-localized T1, T2 and T2* values; the measured values of 18% and 27% are reported as a partial confirmation and are lower than the predictions, so the simulation is not being back-fitted to the measured outcome. The PSF-voxel normalization with factors 0.96 and 1.31 is an explicit correction rather than a hidden rescaling of the target quantity. The data-driven principal-eigenvector combination in the IDEAL-modes reconstruction is a possible source of upward SNR bias for the bSSFP arm and would merit a fixed-weights or split-half robustness check, but this is a statistical/correctness concern rather than a definitional circularity: the paper also compares the IDEAL-modes result with a linear-fit method and with generic IDEAL on averaged phase cycles, and it reports that the derived eigenvectors resemble simulated SSFP mode decays, indicating the result is not purely an artifact of the optimization. Self-citations such as references 9 and 21 provide coil and prior-protocol context and are not load-bearing; the water-concentration reference is attributed to Peters et al. No step in the derivation chain equates a predicted quantity with an input by construction.

Assumptions & free parameters 0 free parameters · 4 assumptions · 0 invented entities

The central claims rely on standard bSSFP signal physics, separately measured relaxation times, and common assumptions for metabolite quantification. No ad hoc fitted parameters or invented entities are introduced.

assumptions (4)
  • domain assumption The analytical bSSFP signal model (Ganter 2006, equations [42-44]) accurately describes the acquired phase-cycled deuterium signal used in the linear fit and simulations.
    Invoked in Methods, 'Spectral fitting' and 'Simulation'; the SNR predictions and the linear fit depend on it.
  • domain assumption The T1 and T2 relaxation times measured non-locally in five subjects are accurate and representative for the subjects whose DMI data are compared.
    Measured by non-localized inversion recovery and spin-echo (Methods 'Non-localized spectroscopy'), used to optimize protocols and in the linear fit.
  • domain assumption The water concentration in the human brain is spatially homogeneous at 10.12 mM for quantitative metabolite mapping.
    Assumed in Methods 'Metabolite quantification'; the paper notes it is approximate and causes slight underestimation.
  • domain assumption The B0 off-resonance map estimated from the lowest SSFP configuration order (F0 mode) using IDEAL is sufficiently accurate for the proposed metabolite estimation methods.
    Both proposed fitting methods use this B0 map (Methods 'Spectral fitting'); errors in this map caused visible artifacts in subject 2 (Results 'In vivo DMI studies').

how reviews work

0 comments
Cite this review

Pith. "Pith review of High-resolution deuterium metabolic imaging of the human brain at 9.4 T using bSSFP spectral-spatial acquisitions." pith.science (2026). https://pith.science/paper/YZGF3L36

@misc{pith2026250118567,
  author       = {Pith},
  title        = {Pith review of: High-resolution deuterium metabolic imaging of the human brain at 9.4 T using bSSFP spectral-spatial acquisitions},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/YZGF3L36}},
  note         = {Machine review of arXiv:2501.18567}
}
read the original abstract

We demonstrated the feasibility of using bSSFP acquisitions for off-resonance insensitive high-resolution [6,6'-2H2]-glucose deuterium metabolic imaging (DMI) studies in the healthy human brain at 9.4T. Balanced SSFP acquisitions have potential to improve the sensitivity of DMI despite the SNR loss of phase-cycling and other human scanner constraints.We investigated two variants of bSSFP acquisitions, namely uniform-weighted multi echo and acquisition-weighted CSI to improve the SNR of deuterium metabolic imaging (DMI) in the brain with oral labelled-glucose intake. Phase-cycling was introduced to make bSSFP acquisitions less sensitive to B0 inhomogeneity. Two SNR optimal methods for obtaining metabolite amplitudes from the phase-cycled data were proposed. The SNR performance of the two bSSFP variants was compared with a standard gradient-spoiled CSI acquisition and subsequent IDEAL processing. In addition, in vivo T1 and T2 of water, glucose and Glx (glutamate+glutamine) were estimated from non-localized inversion recovery and spin-echo measurements.High-resolution whole-brain dynamic quantitative DMI maps were successfully obtained for all three acquisitions. Phase-cycling improved the quality of bSSFP metabolite estimation and provided additional spectral encoding. The SNR improvement was only observed for the CSI variant of bSSFP acquisitions with an average increase of 18% and 27% for glucose and Glx, respectively, compared to the vendor's CSI. ME-bSSFP acquisition achieved higher resolutions than acquisition-weighted CSI and exhibited several qualitative improvements.

Figures

Figures reproduced from arXiv: 2501.18567 by the authors.

Figure 2
Figure 2. In vivo signal efficiency (signal amplitude/√𝑇𝑅) of deuterated metabolites with respect to TR and flip angle for FLASH, FISP and bSSFP acquisitions. The measured in vivo relaxation times used for the simulation are shown in the title of the respective subplots. The SAR limits with respect to TR for three pulse duration are overlaid to show the available parameter space for SNR optimization. The asterisks in the plot… view at source ↗
Figure 3
Figure 3. A) The constructed phantom with various concentrations of four deuterated compounds (blue: water, green: Glucose ,yellow: Glutamic acid, orange : lactate). B) shows the 2H B0 map estimated using the IDEAL algorithm. C) shows better conditioning of the model for matrix inversion with higher number of phase cycles and echoes. The error bars indicate less dispersion due to B0 off-resonance with 18 phase cycles. D) Meta… view at source ↗
Figure 4
Figure 4. In vitro SNR analysis. The metabolite maps in SNR units obtained using all three investigated protocols are shown for the phantom study. The SNR maps are normalized with the PSF voxel volume of the acquisitions for fair comparison. The bar plots show the mean and standard deviation of the SNR within regions-of-interest (ROIs). The vials with the largest concentrations are chosen as ROIs. ROIs are indicated in the me… view at source ↗
Figures from the paper (4 more)
Figure 5
Figure 5. Figure 5: In vivo SNR analysis for all four deuterated metabolites in all three subjects. An exemplary axial slice of the metabolite maps (top) and the SNR distribution over the entire brain (bottom) are shown for the three different acquisition methods. The whole-brain ROIs are…
Figure 6
Figure 6. Figure 6: The CSI-bSSFP maps for all metabolites a) water, b) glucose, c) Glx and d) lactate/ lipid. The first three columns show the three different phase cycle combination methods (linear, IDEAL-modes and standard IDEAL algorithm on averaged phase cycles). SNR maps obtained fr…
Figure 7
Figure 7. Figure 7: Comparison of metabolite maps from the CSI-FISP and CSI-bSSFP acquisitions in subject 1. The 3D maps of three deuterated metabolites (water in SNR units, quantitative glucose and Glx (glutamate+glutamine) maps in mM) measured at different time points after the glucose …
Figure 8
Figure 8. Figure 8: Comparison of metabolite maps from the CSI-FISP and ME-bSSFP acquisitions in subject 2. The 3D maps of three deuterated metabolites (water in SNR units, quantitative glucose and Glx (glutamate+glutamine) maps in mM) measured at different time points after the glucose i…

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

36 extracted references · 32 canonical work pages

  1. [1]

    Simultaneous Assessment of Abnormal Glycolysis and Oxidative Metabolisms in Brain Tumor using In Vivo Deuterium MRS Imaging

    Lu M, Zhu XH, Zhang Y, Low W, Chen W. Simultaneous Assessment of Abnormal Glycolysis and Oxidative Metabolisms in Brain Tumor using In Vivo Deuterium MRS Imaging. In: Proc. Intl. Soc. Mag. Reson. Med. 24 (2016) . Singapore; 2016. https://cds.ismrm.org/protected/16MProceedings/PDFfiles/3962.html. Accessed December 13, 2024

    work page 2016

  2. [2]

    Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo

    De Feyter HM, Behar KL, Corbin ZA, et al. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Science Advances . 2018;4(8):eaat7314. doi:10.1126/sciadv.aat7314

    work page doi:10.1126/sciadv.aat7314 2018

  3. [3]

    Experimental study for cancer diagnosis with positron - labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection

    Fukuda H, Matsuzawa T, Abe Y, et al. Experimental study for cancer diagnosis with positron - labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection. Eur J Nucl Med. 1982;7(7):294-297. doi:10.1007/BF00253423

    work page doi:10.1007/bf00253423 1982

  4. [4]

    Deuterium metabolic imaging – Back to the future

    De Feyter HM, de Graaf RA. Deuterium metabolic imaging – Back to the future. Journal of Magnetic Resonance. 2021;326:106932. doi:10.1016/j.jmr.2021.106932

    work page arXiv 2021

  5. [5]

    Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging

    Segebarth CM, Balériaux DF, Luyten PR, Den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging. Magnetic Resonance in Medicine. 1990;13(1):62-76. doi:10.1002/mrm.1910130108

    work page doi:10.1002/mrm.1910130108 1990

  6. [6]

    Metabolic Imaging and Other Applications of Hyperpolarized 13C1

    Golman K, Petersson JS. Metabolic Imaging and Other Applications of Hyperpolarized 13C1. Academic Radiology. 2006;13(8):932-942. doi:10.1016/j.acra.2006.06.001

    work page doi:10.1016/j.acra.2006.06.001 2006

  7. [7]

    MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST)

    van Zijl PCM, Jones CK, Ren J, Malloy CR, Sherry AD. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proceedings of the National Academy of Sciences. 2007;104(11):4359-4364. doi:10.1073/pnas.0700281104

    work page doi:10.1073/pnas.0700281104 2007

  8. [8]

    On the magnetic field dependence of deuterium metabolic imaging

    de Graaf RA, Hendriks AD, Klomp DWJ, et al. On the magnetic field dependence of deuterium metabolic imaging. NMR in Biomedicine. 2020;33(3):e4235. doi:10.1002/nbm.4235

    work page doi:10.1002/nbm.4235 2020

Show all 36 references
  1. [9]

    Deuterium metabolic imaging in the human brain at 9.4 Tesla with high spatial and temporal resolution

    Ruhm L, Avdievich N, Ziegs T, et al. Deuterium metabolic imaging in the human brain at 9.4 Tesla with high spatial and temporal resolution. NeuroImage. 2021;244:118639. doi:10.1016/j.neuroimage.2021.118639

    2021

  2. [10]

    Deuterium metabolic imaging of the human brain in vivo at 7 T

    Serés Roig E, De Feyter HM, Nixon TW, et al. Deuterium metabolic imaging of the human brain in vivo at 7 T. Magnetic Resonance in Medicine. 2023;89(1):29-39. doi:10.1002/mrm.29439

    2023 doi

  3. [11]

    Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T

    Adamson PM, Datta K, Watkins R, Recht LD, Hurd RE, Spielman DM. Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T. Magnetic Resonance in Medicine. 2024;91(1):39-50. doi:10.1002/mrm.29830

    2024 doi

  4. [12]

    Motion -insensitive, steady -state free precession imaging

    Zur Y, Wood ML, Neuringer LJ. Motion -insensitive, steady -state free precession imaging. Magnetic Resonance in Medicine. 1990;16(3):444-459. doi:10.1002/mrm.1910160311

    1990 doi

  5. [13]

    Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi ‐echo bSSFP: A pancreatic cancer investigation

    Peters DC, Markovic S, Bao Q, et al. Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi ‐echo bSSFP: A pancreatic cancer investigation. Magn Reson Med. 2021;86(5):2604-2617. doi:10.1002/mrm.28906

    2021 doi

  6. [14]

    Deuterium imaging of the Warburg effect at sub-millimolar concentrations by joint processing of the kinetic and spectral dimensions

    Montrazi ET, Bao Q, Martinho RP, et al. Deuterium imaging of the Warburg effect at sub-millimolar concentrations by joint processing of the kinetic and spectral dimensions. NMR in Biomedicine. 2023;36(11):e4995. doi:10.1002/nbm.4995

    2023 doi

  7. [15]

    Fundamentals of balanced steady state free precession MRI

    Bieri O, Scheffler K. Fundamentals of balanced steady state free precession MRI. Journal of Magnetic Resonance Imaging. 2013;38(1):2-11. doi:10.1002/jmri.24163

    2013 doi

  8. [16]

    FISP: A new fast MRI sequence

    Opplet A, Graumann R, Barfuss H, Fischer H, Hertl W, schajor W. FISP: A new fast MRI sequence. Electromedica,. 1986;3(15)

    1986

  9. [17]

    Application of Fourier Transform Spectroscopy to Magnetic Resonance

    Ernst RR, Anderson WA. Application of Fourier Transform Spectroscopy to Magnetic Resonance. Review of Scientific Instruments. 1966;37(1):93-102. doi:10.1063/1.1719961

    1966 doi

  10. [18]

    An analytical solution for the SSFP signal in MRI

    Hänicke W, Vogel HU. An analytical solution for the SSFP signal in MRI. Magnetic Resonance in Medicine. 2003;49(4):771-775. doi:10.1002/mrm.10410

    2003 doi

  11. [19]

    Static susceptibility effects in balanced SSFP sequences

    Ganter C. Static susceptibility effects in balanced SSFP sequences. Magn Reson Med . 2006;56(3):687-691. doi:10.1002/mrm.20986

    2006 doi

  12. [20]

    Multipoint dixon technique for water and fat proton and susceptibility imaging

    Glover GH. Multipoint dixon technique for water and fat proton and susceptibility imaging. Journal of Magnetic Resonance Imaging. 1991;1(5):521-530. doi:10.1002/jmri.1880010504

    1991 doi

  13. [21]

    Double‐tuned 31 P/ 1 H human head array with high performance at both frequencies for spectroscopic imaging at 9.4T

    Avdievich NI, Ruhm L, Dorst J, Scheffler K, Korzowski A, Henning A. Double‐tuned 31 P/ 1 H human head array with high performance at both frequencies for spectroscopic imaging at 9.4T. Magn Reson Med. 2020;84(2):1076-1089. doi:10.1002/mrm.28176

    2020 doi

  14. [22]

    Selection of optimum parameters for pulse Fourier transform nuclear magnetic resonance

    Becker ED, Ferretti JA, Gambhir PN. Selection of optimum parameters for pulse Fourier transform nuclear magnetic resonance. Anal Chem. 1979;51(9):1413-1420. doi:10.1021/ac50045a016

    1979 doi

  15. [23]

    Adaptive reconstruction of phased array NMR imagery

    Walsh DO, Gmitro AF, Marcellin MW. Adaptive reconstruction of phased array NMR imagery. US Patent 6,160,398. 2000;690:682-690

    2000

  16. [24]

    Multicoil Dixon chemical species separation with an iterative least- squares estimation method

    Reeder SB, Wen Z, Yu H, et al. Multicoil Dixon chemical species separation with an iterative least- squares estimation method. Magn Reson Med. 2004;51(1):35-45. doi:10.1002/mrm.10675

    2004 doi

  17. [25]

    Motion -insensitive rapid configuration relaxometry

    Nguyen D, Bieri O. Motion -insensitive rapid configuration relaxometry. Magn R eson Med . 2017;78(2):518-526. doi:10.1002/mrm.26384

    2017 doi

  18. [26]

    Steady state of gradient echo sequences with radiofrequency phase cycling: Analytical solution, contrast enhancement with partial spoiling

    Ganter C. Steady state of gradient echo sequences with radiofrequency phase cycling: Analytical solution, contrast enhancement with partial spoiling. Magn Reson Med . 2006;55(1):98 -107. doi:10.1002/mrm.20736

    2006 doi

  19. [27]

    Image reconstruction in SNR units: A general method for SNR measurement†

    Kellman P, McVeigh ER. Image reconstruction in SNR units: A general method for SNR measurement†. Magnetic Resonance in Med . 2005;54(6):1439 -1447. doi:10.1002/mrm.20713

    2005 doi

  20. [28]

    The Use of an Adaptive Reconstruction for Array Coil Sensitivity Mapping and Intensity Normalization

    Griswold MA, Walsh D, Heidemann R, Haase A, Jakob P. The Use of an Adaptive Reconstruction for Array Coil Sensitivity Mapping and Intensity Normalization. Proceedings of the 10th Annual Meeting of the ISMRM, Honolulu, HI, USA. 2002;43(5):2410

    2002

  21. [29]

    Characterization of Kinetic Isotope Effects and Label Loss in Deuterium -Based Isotopic Labeling Studies

    de Graaf RA, Thomas MA, Behar KL, De Feyter HM. Characterization of Kinetic Isotope Effects and Label Loss in Deuterium -Based Isotopic Labeling Studies. ACS Chem Neurosci . 2021;12(1):234-243. doi:10.1021/acschemneuro.0c00711

    2021 doi

  22. [30]

    Pulseq: A rapid and hardware -independent pulse sequence prototyping framework

    Layton KJ, Kroboth S, Jia F, et a l. Pulseq: A rapid and hardware -independent pulse sequence prototyping framework. Magnetic Resonance in Medicine . 2017;77(4):1544 -1552. doi:10.1002/mrm.26235

    2017 doi

  23. [31]

    Frequency offset corrected inversion (FOCI) pulses for use in localized spectroscopy

    Ordidge RJ, Wylezinska M, Hugg JW, Butterworth E, Franconi F. Frequency offset corrected inversion (FOCI) pulses for use in localized spectroscopy. Magnetic Resonance in Medicine . 1996;36(4):562-566. doi:10.1002/mrm.1910360410

    1996 doi

  24. [32]

    Receive array magnetic resonance spectroscopy: Whitened singular value decomposition (WSVD) gives optimal Bayesian solution

    Rodgers CT, Robson MD. Receive array magnetic resonance spectroscopy: Whitened singular value decomposition (WSVD) gives optimal Bayesian solution. Magnetic Resonance in Medicine. 2010;63(4):881-891. doi:10.1002/mrm.22230

    2010 doi

  25. [33]

    OXSA: An open -source magnetic resonance spectroscopy analysis toolbox in MA TLAB

    Purvis LAB, Clarke WT, Biasiolli L, Valkovič L, Robson MD, Rodgers CT. OXSA: An open -source magnetic resonance spectroscopy analysis toolbox in MA TLAB. PLOS ONE . 2017;12(9):e0185356. doi:10.1371/journal.pone.0185356

    2017 doi

  26. [34]

    Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

    Vanhamme L, van den Boogaart A null, Van Huffel S null. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35-

    1997

  27. [35]

    Glucose uptake and distribution across the human skeleton using state-of-the-art total-body PET/CT

    Lu W, Duan Y, Li K, Qiu J, Cheng Z. Glucose uptake and distribution across the human skeleton using state-of-the-art total-body PET/CT. Bone Res. 2023;11(1):1-9. doi:10.1038/s41413-023- 00268-7 Supporting Information Supporting Information Figure S1: Non-localized inversion re...

    2023 doi

  28. [43]

    doi:10.1006/jmre.1997.1244

    1997

Pith tools

Reviewed August 9, 2026 · model on record in the stance chip above.